Galectin Therapeutics (GALT) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.45% |
| Dec 31, 2025 | -8.17% |
| Sep 30, 2025 | -18.75% |
| Jun 30, 2025 | -19.51% |
| Mar 31, 2025 | -29.72% |
| Sep 30, 2024 | -11.67% |
| Jun 30, 2024 | -13.23% |
| Mar 31, 2024 | 27.57% |
| Dec 31, 2023 | 25.47% |
| Sep 30, 2023 | 14.97% |
| Jun 30, 2023 | 11.35% |
| Mar 31, 2023 | 34.87% |
| Sep 30, 2022 | 17.87% |
| Jun 30, 2022 | 21.51% |
| Mar 31, 2022 | 18.29% |
| Sep 30, 2021 | 17.91% |
| Jun 30, 2021 | 11.91% |
| Mar 31, 2021 | -1.47% |
| Dec 31, 2020 | 0.98% |
| Sep 30, 2020 | 8.84% |
| Jun 30, 2020 | 9.11% |
| Mar 31, 2020 | 8.10% |
| Dec 31, 2019 | 10.27% |
| Sep 30, 2019 | 10.04% |
| Jun 30, 2019 | 8.62% |
| Mar 31, 2019 | -28.22% |
| Dec 31, 2018 | -4.68% |
| Sep 30, 2018 | 0.85% |
| Jun 30, 2018 | 15.54% |
| Mar 31, 2018 | -10.69% |
| Dec 31, 2017 | -20.08% |
| Sep 30, 2017 | -8.85% |
| Jun 30, 2017 | -7.02% |
| Mar 31, 2017 | -2.28% |
| Dec 31, 2016 | 19.15% |
| Sep 30, 2016 | 15.12% |
| Jun 30, 2016 | 17.66% |
| Mar 31, 2016 | 26.33% |
| Dec 31, 2015 | 34.41% |
| Sep 30, 2015 | 49.93% |
| Jun 30, 2015 | 55.89% |